MTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior

Journal of Urology

Volumn 190, Issue 6, 2013, Pages 2288-2295

  Ferrandiz Pulido, Carla ^a   Masferrer, Emili ^c,d   Toll, Agustin ^c   Hernandez Losa, Javier ^b   Mojal, Sergio ^d   Pujol, Ramon M ^c   Ramon Y Cajal, Santiago ^b   De Torres, Ines ^b   Garcia Patos, Vicente ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL DEL MAR   (Spain)

Author keywords

Biological markers; Carcinoma, squamous cell; Immunohistochemistry; MTOR protein, human; Penis

Indexed keywords

BIOLOGICAL MARKER; INITIATION FACTOR 4E; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN P53; TUMOR MARKER;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; DRUG TARGETING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PENIS CARCINOMA; PENIS SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; WART VIRUS;

EID: 84888638541     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.06.015     Document Type: Article

References (30)

1. Mosconi AM, Roila F, Gatta G et al: Cancer of the penis. Crit Rev Oncol Hematol 2005;53:165.
2. Cubilla AL, Lloveras B, Alejo M et al: Value of p16 (INK) 4a in the pathology of invasive penile squamous cell carcinomas: a report of 202 cases. Am J Surg Pathol 2011;35:253.
3. Ferrandiz-Pulido C, Masferrer E, De Torres I et al: Identification and genotyping of human papillomavirus in a Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16 (INK4a) expression, and prognosis. J Am Acad Dermatol 2013;68:73.
4. Cubilla AL: The role of pathologic prognostic factors in squamous cell carcinoma of the penis. World J Urol 2009;27:169.
5. Chaux A, Caballero C, Soares F et al: The prognostic index: a useful pathologic guide for prediction of nodal metastases and survival in penile squamous cell carcinoma. Am J Surg Pathol 2009;33:1049.
6. Lopes A, Bezerra AL, Pinto CA et al: p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol 2002;168:81.
7. Martins AC, Faria SM, Cologna AJ et al: Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J Urol 2002;167:89.
8. Zhu Y, Zhou XY, Yao XD et al: The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery. BJU Int 2007;100:204.
9. Masferrer E, Ferrandiz-Pulido C, Lloveras B et al: MYC copy number gains are associated with poor outcome in penile squamous cell carcinoma. J Urol 2012;188:1965.
10. Populo H, Lopes JM and Soares P: The mTOR signalling pathway in human cancer. Int J Mol Sci 2012;13:1886.
11. Euvrard S, Morelon E, Rostaing L et al: Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med 2012;367:329.
12. Patel V, Marsh CA, Dorsam RT et al: Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer. Cancer Res 2011;71:7103.
13. Feng W, Duan X, Liu J et al: Morphoproteomic evidence of constitutively activated and overexpressed mTOR pathway in cervical squamous carcinoma and high grade squamous intraepithelial lesions. Int J Clin Exp Pathol 2009;2:249.
14. Stankiewicz E, Prowse DM, Ng M et al: Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS One 2011;6:e175.
15. Lavens N, Gupta R and Wood LA: EGFR overexpression in squamous cell carcinoma of the penis. Curr Oncol 2010;17:4.
16. Andersson P Kolaric A, Windahl T et al: PIK3CA, HRAS and KRAS gene mutations in human penile cancer. J Urol 2008;179:2030.
17. Kononen J, Budendorf L, Kallioiemi A et al: Tissue microarrays for high-throughput molecular profiling of tumors specimens. Nat Med 1998;4:844.
18. Castellvi J, Garcia A, Ruiz-Marcellan C et al: Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis. Hum Pathol 2009;40:1418.
19. Cedres S, Montero MA, Martinez P et al: Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM). Lung Cancer 2012;77:192.
20. Detre S, Saclani Jotti G and Dowsett M: A "quickscore" method for immunohistochemical semiquantitation: validation for estrogen receptor in breast carcinomas. J Clin Pathol 1995;48:876.
21. Bennett WP, Hollstein MC, Hsu IC et al: Mutational spectra and immunohistochemical analyses of p53 in human cancers. Chest, suppl., 1992;101:19S.
22. Dancey JE: Therapeutic targets: MTOR and related pathways. Cancer Biol Ther 2006;5:1065.
23. Mizumoto Y, Kyo S, Mori N et al: Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis. Cancer Sci 2007;98:652.
24. Mueller H, Flury N, Eppenberger-Castori S et al: Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients. Int J Cancer 2000;89:384.
25. Givant-Horwitz V, Davidson B, Lazarovici P et al: Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions. Gynecol Oncol 2003;91:160.
26. De Benedetti A and Graff JR: eIF-4E expression and its role in malignancies and metastases. Oncogene 2004;23:3189.
27. Yoshizawa A, Fukuoka J, Shimizu S et al: Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer. Clin Cancer Res 2010;16:240.
28. Furic L, Rong L, Larsson O et al: eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc Natl Acad Sci U S A 2010;107:14134.
29. Li Y, Yue P, Deng X et al: Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E. Neoplasia 2010;12:848.
30. Eichten A, Westfall M, Pietenpol JA et al: Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein. Virology 2002;295:74.